PTC Therapeutics reports Q4 Sephience revenue of $92.5 million
Go back to PTC Therapeutics reports Q4 Sephience revenue of $92.5 million| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 71.79 +1.23 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.56 | 52 Week High | $35.40 | |||
| Open | $71.15 | 52 Week Low | $4.03 | |||
| Day High | $72.68 | P/E | 7.64 | |||
| Day Low | $69.84 | EPS | $9.40 | |||
| Volume | 902,585 | |||||
